about
Antibodies covalently immobilized on actin filaments for fast myosin driven analyte transportFunctional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALLIdentification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemiaA leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia.New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation proceduresCRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signaturesMolecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells.Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation.Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome.The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.The MLL recombinome of acute leukemias in 2013.Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALLEpigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphomaTargeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical modelLCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.Array-based comparative genomic hybridization analysis reveals chromosomal copy number aberrations associated with clinical outcome in canine diffuse large B-cell lymphoma.Acute leukemia subclassification: a marker protein expression perspective.Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.Expression of carp-cdx1, a caudal homolog, in embryos of the carp, Cyprinus carpio.Isolation of carp cDNA clones, representing developmentally-regulated genes, using a subtractive-hybridization strategy.An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts.What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohortsDeciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis.CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia.Sensing protein antigen and microvesicle analytes using high-capacity biopolymer nano-carriers.Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.Expression Profiling of Circulating Microvesicles Reveals Intercellular Transmission of Oncogenic Pathways.Sample solution constraints on motor-driven diagnostic nanodevices.Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation.Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.Mesenchymal stem cells from Shwachman-Diamond syndrome patients display normal functions and do not contribute to hematological defects.High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
P50
Q27316404-95EFC6BA-C625-45B3-95F9-9A586E79D9D1Q28475897-E8358C10-645D-4F35-98AF-9EA403A8521DQ28943326-F9B7E2D8-6362-4ADB-BF8E-EE3A237EA076Q30790942-7734E7FF-8911-49E3-9A61-9BB37CB46166Q31116667-258AD81A-BA5E-4FCA-9208-DC77B003733CQ33429079-7832E20F-DF82-482D-9784-46A1BF98FC4DQ33473001-FC67EF4A-6532-4F08-B114-F8F46E50ADEAQ33480001-42107B58-804E-433E-BBEB-25F633AAD3BEQ33691942-C9EA542F-76F1-4AD4-95B4-174A77A166E5Q34221792-454BF2D9-A91F-4E6C-9516-2A64C2822B63Q34537277-B44755AC-CEB8-4DC3-8A4B-8BEE27C3C1F5Q34651113-F3A0F8E8-30AD-4404-9EBB-28B5D912174FQ34973772-0DDE1C78-764A-4FE6-BA97-B5A4C66CD9B2Q35022504-911C3BCC-8DB5-4122-ABEF-B72380DDD9D1Q35138335-B2B5F151-6F5F-4C8C-8082-9396D1EAC6E8Q35176311-5B677413-9EC1-497E-AF37-B009E7CD1EBDQ35176372-1B0AF389-1AB9-413F-9B4A-348CA3AE9956Q35396525-42C6FAEA-7D28-4434-947B-1A0F0E477442Q35809438-8C4C30FB-BB7E-4784-AA77-685CF3E8AEA3Q36154689-B11FD575-6D63-41DC-8E88-3F5DF2014E90Q36311934-5EBCA88F-D18A-481F-86DD-310C1D00449EQ36311997-065EB3D5-057D-4D4C-B03A-9A24C8475A04Q36751751-DC062456-6AAD-4B05-9330-E211927A4565Q37060647-63D8D01B-E0EE-459B-A46E-5E572A181103Q37273171-CA8FA429-2BE6-4F82-B2FC-D3C2D2C166FFQ37306997-7809921E-843B-4F12-B12A-B81DB2304C63Q37644852-E0DD1B01-42AF-4E24-9D12-B64EDFBB2305Q38815925-EB05B843-7E33-48F4-A69B-06E8FCF24545Q38821571-B6503EAA-115D-4EFD-BD02-2E4D31E6BBF0Q38844207-C65F8989-BBF2-423D-BBDC-3750A6A5E1A0Q38959446-17980ABA-FF9F-42A8-85EF-51BB1B589A7DQ39213277-D5F0E85B-3EAE-47F2-92F8-ECF695846CFBQ39766394-97E5C12D-3FE5-4C32-A438-57F408FDAE0BQ39992854-70AC5511-6082-431D-BB25-A1ADAFDBE32CQ40098619-0DF65826-B47A-43F2-B325-6E99D0342D5FQ40111307-D2EE803F-879E-474A-9127-AC505968BA33Q41259945-95CE68BB-7DBE-4531-A0C6-A563D73106B4Q41508288-88A68849-241D-4DA2-9733-747C19A8CB6AQ41647887-5D86A430-866B-4478-86EA-B195DB501749Q41823245-280CFD7B-F814-41F4-87DD-AA945726E12E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Geertruy Te Kronnie
@ast
Geertruy Te Kronnie
@en
Geertruy Te Kronnie
@es
Geertruy Te Kronnie
@nl
type
label
Geertruy Te Kronnie
@ast
Geertruy Te Kronnie
@en
Geertruy Te Kronnie
@es
Geertruy Te Kronnie
@nl
prefLabel
Geertruy Te Kronnie
@ast
Geertruy Te Kronnie
@en
Geertruy Te Kronnie
@es
Geertruy Te Kronnie
@nl
P106
P21
P31
P496
0000-0001-7143-4795